210 related articles for article (PubMed ID: 21677142)
1. Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.
Li JM; Southerland L; Hossain MS; Giver CR; Wang Y; Darlak K; Harris W; Waschek J; Waller EK
J Immunol; 2011 Jul; 187(2):1057-65. PubMed ID: 21677142
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients.
Li JM; Hossain MS; Southerland L; Waller EK
Blood; 2013 Mar; 121(12):2347-51. PubMed ID: 23325838
[TBL] [Abstract][Full Text] [Related]
3. VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.
Li JM; Darlak KA; Southerland L; Hossain MS; Jaye DL; Josephson CD; Rosenthal H; Waller EK
PLoS One; 2013; 8(5):e63381. PubMed ID: 23723978
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
Roback JD; Hossain MS; Lezhava L; Gorechlad JW; Alexander SA; Jaye DL; Mittelstaedt S; Talib S; Hearst JE; Hillyer CD; Waller EK
J Immunol; 2003 Dec; 171(11):6023-31. PubMed ID: 14634114
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic cell-mediated dissemination of murine cytomegalovirus is regulated by NK cells and immune evasion.
Zhang S; Springer LE; Rao HZ; Espinosa Trethewy RG; Bishop LM; Hancock MH; Grey F; Snyder CM
PLoS Pathog; 2021 Jan; 17(1):e1009255. PubMed ID: 33508041
[TBL] [Abstract][Full Text] [Related]
6. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection.
Munks MW; Pinto AK; Doom CM; Hill AB
J Immunol; 2007 Jun; 178(11):7235-41. PubMed ID: 17513772
[TBL] [Abstract][Full Text] [Related]
7. Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
Hossain MS; Roback JD; Pollack BP; Jaye DL; Langston A; Waller EK
Blood; 2007 May; 109(10):4548-56. PubMed ID: 17289817
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of CD11c on lung immune cells after disseminated murine cytomegalovirus infection.
Liao Y; Liu X; Huang Y; Huang H; Lu Y; Zhang Y; Shu S; Fang F
Virol J; 2017 Jul; 14(1):132. PubMed ID: 28720115
[TBL] [Abstract][Full Text] [Related]
9. Acute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.
Teoh JJ; Gamache AE; Gillespie AL; Stadnisky MD; Yagita H; Bullock TN; Brown MG
J Immunol; 2016 Dec; 197(11):4360-4370. PubMed ID: 27798162
[TBL] [Abstract][Full Text] [Related]
10. The role of decay accelerating factor in the immunopathogenesis of cytomegalovirus infection.
Bani-Ahmad M; El-Amouri IS; Ko CM; Lin F; Tang-Feldman Y; Oakley OR
Clin Exp Immunol; 2011 Feb; 163(2):199-206. PubMed ID: 21166665
[TBL] [Abstract][Full Text] [Related]
11. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
[TBL] [Abstract][Full Text] [Related]
12. Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice.
Rodriguez M; Sabastian P; Clark P; Brown MG
J Immunol; 2004 Nov; 173(10):6312-8. PubMed ID: 15528370
[TBL] [Abstract][Full Text] [Related]
13. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
Orange JS; Wang B; Terhorst C; Biron CA
J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
Robbins SH; Bessou G; Cornillon A; Zucchini N; Rupp B; Ruzsics Z; Sacher T; Tomasello E; Vivier E; Koszinowski UH; Dalod M
PLoS Pathog; 2007 Aug; 3(8):e123. PubMed ID: 17722980
[TBL] [Abstract][Full Text] [Related]
15. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
Delgado M; Reduta A; Sharma V; Ganea D
J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
[TBL] [Abstract][Full Text] [Related]
16. A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus.
Hutchinson S; Sims S; O'Hara G; Silk J; Gileadi U; Cerundolo V; Klenerman P
PLoS One; 2011 Feb; 6(2):e14646. PubMed ID: 21304910
[TBL] [Abstract][Full Text] [Related]
17. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.
Gold MC; Munks MW; Wagner M; Koszinowski UH; Hill AB; Fling SP
J Immunol; 2002 Jul; 169(1):359-65. PubMed ID: 12077265
[TBL] [Abstract][Full Text] [Related]
18. Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.
Holtappels R; Simon CO; Munks MW; Thomas D; Deegen P; Kühnapfel B; Däubner T; Emde SF; Podlech J; Grzimek NK; Oehrlein-Karpi SA; Hill AB; Reddehase MJ
J Virol; 2008 Jun; 82(12):5781-96. PubMed ID: 18367531
[TBL] [Abstract][Full Text] [Related]
19. Dual function of CD70 in viral infection: modulator of early cytokine responses and activator of adaptive responses.
Allam A; Swiecki M; Vermi W; Ashwell JD; Colonna M
J Immunol; 2014 Jul; 193(2):871-8. PubMed ID: 24913981
[TBL] [Abstract][Full Text] [Related]
20. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.
MacDonald MR; Li XY; Stenberg RM; Campbell AE; Virgin HW
J Virol; 1998 Jan; 72(1):442-51. PubMed ID: 9420244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
